These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8141725)

  • 1. Thrombolysis '93--overview and conclusions.
    Thompson PL; Tonkin AM; Aylward P; White H
    Aust N Z J Med; 1993 Dec; 23(6):774-7. PubMed ID: 8141725
    [No Abstract]   [Full Text] [Related]  

  • 2. Delays in thrombolytic therapy for acute myocardial infarction in Finland. Results of a national thrombolytic therapy delay study. Finnish Hospitals' Thrombolysis Survey Group.
    Hirvonen TP; Halinen MO; Kala RA; Olkinuora JT
    Eur Heart J; 1998 Jun; 19(6):885-92. PubMed ID: 9651712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Are ECG criteria for indications for thrombolysis in acute myocardial infarct defined too narrowly?].
    Weiss P; Sarasin C; Ritz R; Pfisterer M
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1829-32. PubMed ID: 1754866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
    Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
    Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1.
    Lambrew CT; Bowlby LJ; Rogers WJ; Chandra NC; Weaver WD
    Arch Intern Med; 1997 Dec 8-22; 157(22):2577-82. PubMed ID: 9531226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Expected infarct size without thrombolysis', a concept that predicts immediate and long-term benefit from thrombolysis for evolving myocardial infarction.
    Arnold AE; Simoons ML
    Eur Heart J; 1997 Nov; 18(11):1736-48. PubMed ID: 9402448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the experimental myocardial infarction to the clinical acute myocardial infarction: limitations of thrombolytic therapy.
    Marzilli M
    Int J Cardiol; 1995 Aug; 49 Suppl():S71-5. PubMed ID: 7591319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy for acute myocardial infarction in the 1990s.
    Effron MB; Morales RE
    Md Med J; 1991 Jun; 40(6):485-91. PubMed ID: 1830634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction.
    Zahger D; Karagounis LA; Cercek B; Anderson JL; Sorensen S; Moreno F; Shah PK
    Am J Cardiol; 1995 Oct; 76(11):749-52. PubMed ID: 7572648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy.
    Kono T; Morita H; Nishina T; Fujita M; Hirota Y; Kawamura K; Fujiwara A
    J Am Coll Cardiol; 1996 Mar; 27(4):774-8. PubMed ID: 8613602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis in myocardial infarction--for whom?
    Kuruvilla TK
    J Assoc Physicians India; 1992 Mar; 40(3):210. PubMed ID: 1634498
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of thrombolysis for myocardial infarction in Israel].
    Behar S
    Harefuah; 1992 Jun; 122(12):753-6, 820. PubMed ID: 1505818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
    Tebbe U; Windeler J; Boesl I; Hoffmann H; Wojcik J; Ashmawy M; Rüdiger Schwarz E; von Loewis P; Rosemeyer P; Hopkins G
    J Am Coll Cardiol; 1995 Aug; 26(2):365-73. PubMed ID: 7608436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age on myocardial infarction and thrombolysis.
    Morgan B; Emerman CL
    Am J Emerg Med; 1995 Mar; 13(2):196-8. PubMed ID: 7893308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delay to thrombolysis in myocardial infarction.
    Smith RE; Martin JF
    Q J Med; 1993 Jan; 86(1):73. PubMed ID: 8438055
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed thrombolytic treatment of older patients with acute myocardial infarction.
    McLaughlin TJ; Gurwitz JH; Willison DJ; Gao X; Soumerai SB
    J Am Geriatr Soc; 1999 Oct; 47(10):1222-8. PubMed ID: 10522956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity and response of chest pain during thrombolytic therapy for acute myocardial infarction: a useful indicator of myocardial salvage and infarct size.
    Christian TF; Gibbons RJ; Hopfenspirger MR; Gersh BJ
    J Am Coll Cardiol; 1993 Nov; 22(5):1311-6. PubMed ID: 8227785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis in myocardial infarction--for whom?
    Kumar H
    J Assoc Physicians India; 1992 Jul; 40(7):495-6. PubMed ID: 1484057
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombolytic therapy in acute myocardial infarct in 1992].
    Bergovec M
    Lijec Vjesn; 1993; 115(5-6):170-8. PubMed ID: 8302141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.